Table 5. Association between TRIM29 expression and clinicopathological characteristics in 108 nasopharyngeal carcinomas.

Variable		Expression level
	n	Low(0-4)	High(5-8)	P
Gender
Male	72	33	39	0.683
Female	36	18	18
Age(y)
<50	66	33	33	0.469
≥50	42	18	24
Primary tumor(T) stage
T1-2	30	15	15	0.720
T3-4	78	36	42
lymph node(N) metastasis
N0	45	34	11	0.000#
N1-3	63	17	46
Distant metastasis(M)
M0	77	45	32	0.000#
M1	31	6	25
Clinical TNM stage
I-II	19	13	6	0.041*
III-IV	89	38	51

^#P<0.01 by χ² test, N0 vs.N1-3; M0 vs.M1.

^*P<0.05 by χ² test, TNM stage I-II vs. III-IV.